Martin Wissing

539 total citations
17 papers, 409 citations indexed

About

Martin Wissing is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Transplantation. According to data from OpenAlex, Martin Wissing has authored 17 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Public Health, Environmental and Occupational Health and 4 papers in Transplantation. Recurrent topics in Martin Wissing's work include Renal Transplantation Outcomes and Treatments (4 papers), Organ Transplantation Techniques and Outcomes (4 papers) and Organ Donation and Transplantation (3 papers). Martin Wissing is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Organ Transplantation Techniques and Outcomes (4 papers) and Organ Donation and Transplantation (3 papers). Martin Wissing collaborates with scholars based in Belgium, United States and United Kingdom. Martin Wissing's co-authors include Daniel Abramowicz, P Kinnaert, L De Pauw, P Vereerstraeten, Piero Marchetti, Philip Home, Paul Keown, Alan G. Jardine, Francesco Dotta and Kazuharu Uchida and has published in prestigious journals such as European Journal of Immunology, Transplantation and Vaccine.

In The Last Decade

Martin Wissing

17 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Wissing Belgium 9 224 157 87 67 67 17 409
Abanti Chaudhuri United States 12 164 0.7× 122 0.8× 96 1.1× 27 0.4× 70 1.0× 35 501
William McKane United Kingdom 15 161 0.7× 176 1.1× 54 0.6× 25 0.4× 33 0.5× 30 481
Anh-Dung Hoang Belgium 7 228 1.0× 182 1.2× 41 0.5× 20 0.3× 37 0.6× 11 340
Eduardo Mancilla-Urrea Mexico 6 284 1.3× 121 0.8× 109 1.3× 20 0.3× 92 1.4× 14 346
Ana Ávila Spain 11 161 0.7× 88 0.6× 60 0.7× 20 0.3× 60 0.9× 34 300
Inge B. Brekke Norway 12 316 1.4× 302 1.9× 50 0.6× 29 0.4× 39 0.6× 22 555
Andreas G. Tzakis United States 10 245 1.1× 372 2.4× 126 1.4× 16 0.2× 49 0.7× 12 577
David E. R. Sutherland United States 9 131 0.6× 202 1.3× 91 1.0× 55 0.8× 13 0.2× 11 385
Luiz E. Ianhez Brazil 13 190 0.8× 119 0.8× 46 0.5× 26 0.4× 15 0.2× 18 422
Tracey Ying Australia 9 235 1.0× 156 1.0× 43 0.5× 15 0.2× 45 0.7× 22 406

Countries citing papers authored by Martin Wissing

Since Specialization
Citations

This map shows the geographic impact of Martin Wissing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Wissing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Wissing more than expected).

Fields of papers citing papers by Martin Wissing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Wissing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Wissing. The network helps show where Martin Wissing may publish in the future.

Co-authorship network of co-authors of Martin Wissing

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Wissing. A scholar is included among the top collaborators of Martin Wissing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Wissing. Martin Wissing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kianda, M., Lidia Ghisdal, Nilüfer Broeders, et al.. (2013). Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study. Nephrology Dialysis Transplantation. 29(2). 463–466. 8 indexed citations
2.
Kianda, M., Martin Wissing, Jean‐Michel Hougardy, et al.. (2012). Does Loss to Follow-Up Affects Outcomes of Renal Transplantation? A Retrospective Study of 849 Patients. Transplantation. 94(10S). 845–845. 1 indexed citations
3.
Vereerstraeten, P, Martin Wissing, Nilüfer Broeders, et al.. (2010). [Twenty-five years of calcineurin inhibitors use in kidney transplantation at Erasme Hospital].. PubMed. 31(2). 93–101. 1 indexed citations
4.
Vincent, Jean‐Louis, et al.. (2009). Non–Heart-Beating Donors: An Inquiry to ICU Nurses in a Belgian University Hospital. Transplantation Proceedings. 41(2). 579–581. 8 indexed citations
5.
Wilkinson, Alan, Jaime A. Davidson, Francesco Dotta, et al.. (2005). Guidelines for the treatment and management of new‐onset diabetes after transplantation1. Clinical Transplantation. 19(3). 291–298. 180 indexed citations
6.
Abramowicz, Daniel, Yves Vanrenterghem, Jean‐Paul Squifflet, et al.. (2005). Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial. Clinical Transplantation. 19(4). 475–482. 19 indexed citations
7.
Velez‐Roa, Sonia, Martin Wissing, Alberto Porta, et al.. (2004). Acute arterio-venous fistula occlusion decreases sympathetic activity and improves baroreflex control in kidney transplanted patients. Nephrology Dialysis Transplantation. 19(6). 1606–1612. 20 indexed citations
8.
Rossi, Camélia, Marie‐Luce Delforge, Martin Wissing, et al.. (2001). FATAL PRIMARY INFECTION DUE TO HUMAN HERPESVIRUS 6 VARIANT A IN A RENAL TRANSPLANT RECIPIENT. Transplantation. 71(2). 288–292. 55 indexed citations
9.
Araujo, Zaı̈da, Hubertine Heremans, Patrick Stordeur, et al.. (2000). IFN-γ, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice. Vaccine. 18(17). 1822–1829. 4 indexed citations
10.
Vereerstraeten, P, Martin Wissing, L De Pauw, Daniel Abramowicz, & P Kinnaert. (1999). Male recipients of kidneys from female donors are at increased risk of graft loss from both rejection and technical failure. Clinical Transplantation. 13(2). 181–186. 48 indexed citations
11.
Abramowicz, Daniel & Martin Wissing. (1999). Induction protocols: yesterday, today, and tomorrow. Transplantation Proceedings. 31(1-2). 1100–1101. 3 indexed citations
12.
Scully, Ralph, Stephen Cobbold, Andrew L. Mellor, et al.. (1997). A role for Th2 cytokines in the suppression of CD8+ T cell‐mediated graft rejection. European Journal of Immunology. 27(7). 1663–1670. 35 indexed citations
13.
Willems, Fabienne, Fabienne Andris, Daqi Xu, et al.. (1995). The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation. International Immunology. 7(10). 1593–1598. 14 indexed citations
14.
Wissing, Martin, Daniel Abramowicz, Fabienne Willems, et al.. (1995). Emergence of Th2-like cells after anti-CD3 monoclonal antibody administration in mice.. PubMed. 27(1). 378–9. 3 indexed citations
15.
Willems, Fabienne, Fabienne Andris, Daniel Abramowicz, et al.. (1995). Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals.. PubMed. 27(1). 1425–7. 5 indexed citations
16.
Wissing, Martin, et al.. (1995). Early neutralization of IL-4 but not of IL-10 abrogates neonatal induction of transplantation tolerance in mice.. PubMed. 27(1). 186–7. 3 indexed citations
17.
Dubey, Caroline, J Kuhn, Martin Wissing, et al.. (1992). Susceptibility and resistance to autoimmunity following neonatal injection of semi-allogeneic spleen cells in rats. Journal of Autoimmunity. 5(5). 629–640. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026